-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Stock symbol
-
EFX
-
Transactions as of
-
Apr 28, 2025
-
Transactions value $
-
-$1,797,841
-
Form type
-
4
-
Date filed
-
4/30/2025, 04:21 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EFX |
Common Stock |
Options Exercise |
$3.89M |
+22.2K |
+15.56% |
$175.48 |
165K |
Apr 28, 2025 |
Direct |
F1, F2 |
| transaction |
EFX |
Common Stock |
Sale |
-$5.69M |
-22.2K |
-13.47% |
$256.61 |
142K |
Apr 28, 2025 |
Direct |
F1, F2 |
| holding |
EFX |
Common Stock |
|
|
|
|
|
43.4K |
Apr 28, 2025 |
2-yr 2023 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
10.5K |
Apr 28, 2025 |
2-yr 2025 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
9.53K |
Apr 28, 2025 |
2-yr Feb 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
24.1K |
Apr 28, 2025 |
2-yr Jul 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
24.2K |
Apr 28, 2025 |
3-yr Jul 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
12.3K |
Apr 28, 2025 |
4-yr 2021 GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-22.2K |
-100% |
$0.00 |
0 |
Apr 28, 2025 |
Common Stock |
22.2K |
$175.48 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: